A polyphenol-assisted IL-10 mRNA delivery system for ulcerative colitis

Ex vivo
DOI: 10.1016/j.apsb.2022.03.025 Publication Date: 2022-04-02T23:48:01Z
ABSTRACT
With the development of synthesis technology, modified messenger RNA (mRNA) has emerged as a novel category therapeutic agents for broad diseases. However, effective intracellular delivery mRNA remains challenging, especially its sensitivity to enzymatic degradation. Here, we propose polyphenol-assisted handy strategy efficient in vivo IL-10 mRNA. binds polyphenol ellagic acid through supramolecular binding yield negatively charged core, followed by complexing with linear polyetherimide and coating bilirubin-modified hyaluronic obtain layer-by-layer nanostructure. The nanostructure specifically up-regulated level IL-10, effectively inhibited expression inflammatory factors, promoted mucosal repair, protected colonic epithelial cells against apoptosis, exerted potent efficacy dextran sulfate sodium salt-induced acute chronic murine models colitis. designed system without systemic toxicity potential facilitate promising platform ulcerative colitis treatment.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (40)
CITATIONS (29)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....